510(k) K212121
K212121 is an FDA 510(k) premarket notification submitted by Vaporox, Inc. for the device "VHT-200 Wound Treatment System". The FDA issued a decision of Substantially Equivalent on March 23, 2023. The device falls under product code KPJ (Chamber, Oxygen, Topical, Extremity), a Class II device regulated under 21 CFR 878.5650. Vaporox, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 23, 2023
- Date Received
- July 7, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Chamber, Oxygen, Topical, Extremity
- Device Class
- Class II
- Regulation Number
- 878.5650
- Review Panel
- SU
- Submission Type